Policy Briefings

Lindus Health Announces Strategic Partnership with Quotient Sciences to Accelerate Phase I–IIa Studies

uBriGene Biosciences Forms CDMO Partnership with Circurna to Advance circRNA Therapeutics

CHA Biotech Subsidiary Matica Biolabs Signs CDMO Deal for TiCARos’ Solid Tumour CAR-T Programme

Tivic Health Acquires Scorpius Assets and Launches Velocity Bioworks as New CDMO Unit

Tjoapack Announces New 170,000 sq ft U.S. Facility to Expand Packaging Capabilities by 2027

Akadeum Life Sciences Unveils CDMO Alliance with Charles River and ElevateBio

AST Announces Strategic Partnership with Marchesini Group to Strengthen Sterile Fill-Finish Capabilities

Bora Pharmaceuticals Forms Alliance with Corealis Pharma to Streamline OSD Development

ProBioGen Partners with Spica Therapeutics to Advance ST101 Cell Line Development

GlycoNex Signs CDMO Agreement to Manufacture CC001 for Japan Phase 1/2a Trial

Andelyn Biosciences Partners with Jaguar Gene Therapy for Late-Stage Manufacturing of JAG201

Saya Biologics Partners with Enzene to Develop and Manufacture Two Osteoporosis Therapies for Mexico

SCTbio Forms Strategic Collaboration with Fortrea to Accelerate Cell and Gene Therapy Development

Eckert & Ziegler Signs Supply Agreement with SK Biopharmaceuticals for GMP Actinium-225

Luxna Biotech Expands Partnership with BioSpring to Advance Oligonucleotide Therapeutics

AsymBio Opens Shanghai Fengxian Manufacturing Base to Expand Global Biologics CDMO Capacity

Quotient Sciences Forms Multi-Year AI Partnership with Intrepid Labs to Accelerate Early Drug Development

Pace Appoints Ken Beyer as the New CEO